The antiviral drug Paxlovid reduces the risk of getting long COVID
The antiviral medication Paxlovid seems to reduce the chance of developing long COVID, researchers report. In a large study of veterans’ medical records, Paxlovid lowered a person’s chance of landing in the hospital or dying from all causes in the six months following a COVID-19 infection. And the drug reduced the risk of developing 10 of 13 long-term health problems, researchers report March 23 in JAMA Internal Medicine.
Recent Posts
REALTORS® Help You Bring It Home
Better Understand Your Listing Options When You Sell
Giant cookies are the rage. We tried San Antonio bakeries and chains to see if bigger is really better.
'It's about censorship, erasure and control': The GOP's push for parental rights
New Tex-Mex restaurant taking over former Don Adolfo’s Bar and Grill space in North San Antonio
Attorney General Ken Paxton’s former aides win $6.6 million in whistleblower case
Texas craft brewers lobby for state bills that would let them deliver to customers, incentivize grain donation
Texas Attorney General sues San Antonio to stop it from paying for out-of-state abortion travel
Texas measles cases jump to 481 as hospitalizations continue to rise
Homegrown San Antonio sando shop Wicked Wich teases new location
"My job is to find and attract mastery-based agents to the office, protect the culture, and make sure everyone is happy! "